Characterization of proapoptotic compounds from the bark of Garcinia oblongifolia

Journal of Natural Products

Volumn 77, Issue 5, 2014, Pages 1111-1116

  Feng, Chao ^a   Huang, Sheng Xiong ^b   Gao, Xue Mei ^c   Xu, Hong Xi ^d,e   Luo, Kathy Qian ^f  

^a HONG KONG UNIVERSITY OF SCIENCE AND TECHNOLOGY   (Hong Kong)

^b KUNMING INSTITUTE OF BOTANY   (China)

^c YUNNAN MINZU UNIVERSITY   (China)

^d SHANGHAI UNIVERSITY OF TRADITIONAL CHINESE MEDICINE   (China)

^e Engineering Research Center of Shanghai Colleges for TCM New Drug Discovery   (China)

^f Nanyang Technological University   (Singapore)

Author keywords

[No Author keywords available]

Indexed keywords

1,3,5 TRIHYDROXY 13,13 DIMETHYL 2H PYRAN[7,6 B]XANTHONE; CASPASE 3; CYTOTOXIC AGENT; EPIDERMAL GROWTH FACTOR RECEPTOR 2; GARCICOWIN B; HERBACEOUS AGENT; MULTIDRUG RESISTANCE PROTEIN; NIGROLINEAXANTHONE T; OBLONGIFOLIN F; OBLONGIFOLIN G; UNCLASSIFIED DRUG;

ANTINEOPLASTIC ACTIVITY; APOPTOSIS; ARTICLE; BARK; BREAST CANCER; CELL CYCLE; COLON CANCER; CONTROLLED STUDY; CYTOTOXICITY; DRUG ISOLATION; DRUG SCREENING; FEMALE; FLUORESCENCE MICROSCOPY; GARCINIA; GARCINIA OBLONGIFOLIA; HELA CELL LINE; HEPG2 CELL LINE; HUMAN; HUMAN CELL; IC 50;

AMINO ACID CHLOROMETHYL KETONES; ANTINEOPLASTIC AGENTS, PHYTOGENIC; CASPASE 3; CASPASE INHIBITORS; FEMALE; GARCINIA; HELA CELLS; HEP G2 CELLS; HUMANS; INHIBITORY CONCENTRATION 50; MOLECULAR STRUCTURE; P-GLYCOPROTEIN; PLANT BARK; RECEPTOR, ERBB-2; XANTHONES;

EID: 84901667088     PISSN: 01633864     EISSN: 15206025     Source Type: Journal    
DOI: 10.1021/np4007316     Document Type: Article

References (21)

1. Hertzberg, R. P.; Caranfa, M. J.; Hecht, S. M. Biochemistry 1989, 28, 4629-4638
2. Bhalla, K.; Ibrado, A. M.; Tourkina, E.; Tang, C.; Mahoney, M. E.; Huang, Y. Leukemia 1993, 7, 563-568
3. Takano, Y.; Okudaira, M.; Harmon, B. V. Pathol. Res. Pract. 1993, 189, 197-203
4. Fearnhead, H. O.; Chwalinski, M.; Snowden, R. T.; Ormerod, M. G.; Cohen, G. M. Biochem. Pharmacol. 1994, 48, 1073-1079
5. Kerr, J. F.; Wyllie, A. H.; Currie, A. R. Br. J. Cancer 1972, 26, 239-257
6. Platt, N.; da Silva, R. P.; Gordon, S. Trends Cell Biol. 1998, 8, 365-372
7. Luo, K. Q.; Yu, V. C.; Pu, Y.; Chang, D. C. Biochem. Biophys. Res. Commun. 2001, 283, 1054-1060
8. Tian, H.; Ip, L.; Luo, H.; Chang, D. C.; Luo, K. Q. Br. J. Pharmacol. 2007, 150, 321-334
9. Huang, S.-X.; Feng, C.; Zhou, Y.; Xu, G.; Han, Q.-B.; Qiao, C.-F.; Chang, D. C.; Luo, K. Q.; Xu, H.-X. J. Nat. Prod. 2009, 72, 130-135
10. Xu, G.; Kan, W. L. T.; Zhou, Y.; Song, J. Z.; Han, Q. B.; Qiao, C. F.; Cho, C. H.; Rudd, J. A.; Lin, G.; Xu, H. X. J. Nat. Prod. 2010, 73, 104-108
11. Zhang, H.; Tao, L.; Fu, W.-W.; Liang, S.; Yang, Y.-F.; Yuan, Q.-H.; Yang, D.-J.; Lu, A.-P.; Xu, H.-X. J. Nat. Prod. 2014, 77, in press, DOI: 10.1021/np500124e.
12. Jordan, M. A.; Thrower, D.; Wilson, L. J. Cell Sci. 1992, 102, 401-416
13. Long, B. H.; Fairchild, C. R. Cancer Res. 1994, 54, 4355-4361
14. Jordan, M. A.; Wendell, K.; Gardiner, S.; Derry, W. B.; Copp, H.; Wilson, L. Cancer Res. 1996, 56, 816-825
15. Freudenberg, J. A.; Wang, Q.; Katsumata, M.; Drebin, J.; Nagatomo, I.; Greene, M. I. Exp. Mol. Pathol. 2009, 87, 1-11
16. Hall, M. D.; Handley, M. D.; Gottesman, M. M. Trends Pharmacol. Sci. 2009, 30, 546-556
17. Wen, X. F.; Yang, G.; Mao, W.; Thornton, A.; Liu, J.; Bast, R. C., Jr.; Le, X. F. Oncogene 2006, 25, 6986-6996
18. Tian, H.-L.; Yu, T.; Xu, N.-N.; Feng, C.; Zhou, L.-Y.; Luo, H.-W.; Chang, D. C.; Le, X.-F.; Luo, K. Q. Cancer Lett. 2010, 297, 18-30
19. Alvarez, M.; Paull, K.; Monks, A.; Hose, C.; Lee, J. S.; Weinstein, J.; Grever, M.; Bates, S.; Fojo, T. J. Clin. Invest. 1995, 95, 2205-2214
20. Feng, C.; Zhou, L.-Y.; Yu, T.; Xu, G.; Tian, H.-L.; Xu, J.-J.; Xu, H.-X.; Luo, K. Q. Int. J. Cancer 2012, 131, 1445-1454
21. Monks, A.; Scudiero, D.; Skehan, P.; Shoemaker, R.; Paull, K.; Vistica, D.; Hose, C.; Langley, J.; Cronise, P.; Vaigro-Wolff, A.; Gray-Goodrich, M.; Campbell, H.; Mayo, J.; Boyd, M. J. Natl. Cancer Inst. 1991, 83, 757-766